Literature DB >> 22856658

Cocaine toxicity and hepatic oxidative stress.

V Vitcheva1.   

Abstract

Cocaine belongs to the group of psychostimulants and together with amphetamines has been recognized as one of the most significant examples of drug abuse. Cocaine abuse is due to intense feelings of euphoria, friendliness, empathy, and hyperactivity, which result from its potent inhibitory effects on presynaptic dopamine and noradrenaline re-uptake. Misuse of cocaine can induce severe toxic effects, including neurotoxicity, cardiotoxicity, hepatotoxicity. There are a number of data, both experimental and clinical, regarding its hepatotoxic effects, associated with lipid peroxidation-induced oxidative damage. The oxidative metabolism of cocaine to reactive oxygen species (ROS) like nitrogen peroxide and superoxide anion radicals are thought to be responsible for the cocaine associated liver injury. This review summarizes the present information on cocaine hepatic biotransformation and the possible role of its oxidative metabolism in cocaine-induced hepatic injury.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22856658     DOI: 10.2174/092986712803988929

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  11 in total

1.  Substance use disorder is associated with alcohol-associated liver disease in patients with alcohol use disorder.

Authors:  Augustin G L Vannier; Vladislav Fomin; Raymond T Chung; Suraj J Patel; Esperance Schaefer; Russell P Goodman; Jay Luther
Journal:  Gastro Hep Adv       Date:  2022-03-30

Review 2.  Biomarkers of drug-induced liver injury: progress and utility in research, medicine, and regulation.

Authors:  Mitchell R McGill; Hartmut Jaeschke
Journal:  Expert Rev Mol Diagn       Date:  2018-08-13       Impact factor: 5.225

3.  Continued Substance Use Among People Living With HIV-Hepatitis-C Co-Infection and Receiving Antiretroviral Therapy.

Authors:  Seth C Kalichman; Christopher Washington; Christopher Kegler; Tamar Grebler; Moira O Kalichman; Chauncey Cherry; Lisa Eaton
Journal:  Subst Use Misuse       Date:  2015-11-19       Impact factor: 2.164

4.  Cannabidiol rescues acute hepatic toxicity and seizure induced by cocaine.

Authors:  Luciano Rezende Vilela; Lindisley Ferreira Gomides; Bruna Araújo David; Maísa Mota Antunes; Ariane Barros Diniz; Fabrício de Araújo Moreira; Gustavo Batista Menezes
Journal:  Mediators Inflamm       Date:  2015-04-27       Impact factor: 4.711

5.  Global Mortality Burden of Cirrhosis and Liver Cancer Attributable to Injection Drug Use, 1990-2016: An Age-Period-Cohort and Spatial Autocorrelation Analysis.

Authors:  Jin Yang; Yunquan Zhang; Lisha Luo; Runtang Meng; Chuanhua Yu
Journal:  Int J Environ Res Public Health       Date:  2018-01-22       Impact factor: 3.390

6.  Reversible Fulminant Hepatitis Secondary to Cocaine in the Setting of β-Blocker Use.

Authors:  Rohan Sharma; Nidhi Kapoor; Kaustubh Suresh Chaudhari; Robert Hal Scofield
Journal:  J Investig Med High Impact Case Rep       Date:  2020 Jan-Dec

7.  Harnessing reactive oxygen/nitrogen species and inflammation: Nanodrugs for liver injury.

Authors:  Min Liu; Qiong Huang; Yan Zhu; Li Chen; Yumei Li; Zhicheng Gong; Kelong Ai
Journal:  Mater Today Bio       Date:  2022-02-08

8.  Cysteine Metabolism and Oxidative Processes in the Rat Liver and Kidney after Acute and Repeated Cocaine Treatment.

Authors:  Danuta Kowalczyk-Pachel; Małgorzata Iciek; Karolina Wydra; Ewa Nowak; Magdalena Górny; Małgorzata Filip; Lidia Włodek; Elżbieta Lorenc-Koci
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

Review 9.  Cardiovascular and Hepatic Toxicity of Cocaine: Potential Beneficial Effects of Modulators of Oxidative Stress.

Authors:  Manuela Graziani; Letizia Antonilli; Anna Rita Togna; Maria Caterina Grassi; Aldo Badiani; Luciano Saso
Journal:  Oxid Med Cell Longev       Date:  2015-12-28       Impact factor: 6.543

10.  Aripiprazole-induced Hepatitis: A Case Report.

Authors:  Lígia Castanheira; Elsa Fernandes; Pedro Levy; Ricardo Coentre
Journal:  Clin Psychopharmacol Neurosci       Date:  2019-11-20       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.